Navigation Links
Denver Based Company Accelerates the Race to Cure Cancer by Improving How Clinical Trials are Managed

DENVER, June 19, 2015 /PRNewswire/ -- The process of cancer clinical trials is broken. The majority of cancer patients in the U.S. have very limited access to the host of potentially life-saving clinical trials that are currently underway across the country. The investigational drugs they offer today in many cases will eventually become the standard of cancer treatment tomorrow. Yet more than 95% of patients who would qualify, never have the opportunity to participate in the clinical trials needed for the FDA to approve these modern anticancer drugs. The challenge with cancer clinical research is twofold. First, each trial is available at only a limited number of centers around the country. Second, patients receive care in a system of thousands of cancer centers and clinics that, if they conduct clinical trials at all, work independently from one another.

MD Anderson, Memorial Sloan Kettering, Cornell University – just a few of the top cancer centers in the U.S., but unless you live near these centers or can afford to relocate for treatment, accessing world-class cancer clinical trials may be difficult. Denver based company Pharmatech is completely changing how clinical trials studies enroll cancer patients by offering a patient centered, on-demand research alternative. Pharmatech helps cancer patients identify the right trial opportunity, then activates that trial at a nearby treatment center using a Just-In-Time delivery model. The Just-In-Time research system was originally conceived by Pharmatech's founder Dr. Matthew Wiener, and its development has been supported by grants from the National Cancer Institute. According to Rob Bohacs, Pharmatech's CEO, "The process of developing patient-centric cancer trials is a breakthrough in helping both patients and pharmaceutical companies. Patient's would like to learn about clinical trials, but most can't relocate to Houston or New York just to be eligible for a trial, so why not bring the trial to the patient?"

Pharmatech's network of 300+ research sites (all independently owned) spans most of the U.S. The Just-In-Time system allows activation of any of the clinical trials in Pharmatech's portfolio, within 10 days of confirming patient interest and fit with a specific study. In addition, patients who are very interested in clinical trial participation can enroll in Pharmatech's AccessPPM protocol – a molecular diagnostic registry that analyzes an individual's cancer related genetic mutations together with their clinical and treatment history to match the patient with the best next-generation, precision cancer medicine clinical trial treatment opportunities. 

The main challenge today is that patients cannot identify or easily connect with the right study. "Finding the right trials is incredibly complex for a physician, let alone a patient," according to Rob Bohacs. " is simply unmanageable for patients as the terminology and specific information is difficult to interpret, hence why we are launching – a patient website that allows patients to receive weekly updates that pertain to their cancer type and where they may have that study opened. The website is set to go live by summer and will allow patients to setup a profile, receive weekly emails about clinical trials that match their disease, speak to one of our cancer experts, then refer themselves to a clinical trial center NEAR them." 

Major Pharmaceuticals are collaborating with Pharmatech to improve the process of clinical trials. 

About Pharmatech, Inc.
Pharmatech, Inc. is an oncology Contract Research Organization (CRO) that manages clinical trial processes. Through an organized network of cancer clinics, the company focuses on advancing the development of products for a broad range of pharmaceutical and biotechnology companies, and on promoting the inclusion of clinical trials in the spectrum of patient treatment options.

For more information about Pharmatech, please visit: or contact us at


SOURCE Pharmatech, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed
2. Colorado Eye Care: Vision Care Specialists Expands Hours, adds Optometrists to Denver Locations
3. ECRI Institutes New Diagnostic Technology Boot Camp Offers Practical Strategies for Evidence-based Decision Making
4. Florida Institute Funds Tampa-based TransGenex Nanobiotech, Inc.
5. Matthews Introduces New MEK-Based, Fast Dry Ink Ideal For The Consumer Packaged Goods And Pharmaceutical Markets
6. BioAtla Receives $30 Million Equity Investment From China-based Investor Group
7. Altan Pharma Announces Acquisition of the GES Group, a Specialty Pharmaceutical Company Based in Spain
8. Indonesian academics and experts call for an evidence-based public health response to drugs in Indonesia
9. Availity to Share Insights, Tools and Strategies at AHIP 2015 to Enable Health Plans to Achieve Long-term, Sustainable Success in an Evolving Value-based Environment
10. GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines
11. North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019
Post Your Comments:
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... ... year at Western Pennsylvania & Ohio Valley Oral & Maxillofacial Surgery. This cutting-edge ... from All-on-4® full arch dental implants to predictable jaw surgery with ...
(Date:10/8/2019)... ... October 08, 2019 , ... Fresno resident Regina Tanner has been selected by ... donor honoree. Regina will walk alongside the float, Light in the Darkness, during the ... and attorney, became a living organ donor in the fall of 2016 when her ...
(Date:10/8/2019)... ... ... A free, interactive event highlighting innovations and ideas helping people with Parkinson’s ... leaders, innovators and health experts, will display innovations that could help people with Parkinson’s ... CT on October 19 at the Coppertank Event Center in Austin, the event is ...
Breaking Medicine Technology:
(Date:10/15/2019)... ... 2019 , ... Nashville Fertility Center (NFC) is proud to announce that ... practice. In addition to treating general infertility, Dr. Van Heertum offers expertise in fertility ... forward to Dr. Van Heertum joining the practice and believes she is the perfect ...
(Date:10/11/2019)... ... October 11, 2019 , ... A Topping Out event was hosted ... by general contractors Adolfson & Peterson Construction. The event celebrated reaching the final height ... Road in Dallas. The first of its kind in Texas, STA’s facility will be ...
(Date:10/10/2019)... ... 10, 2019 , ..., a leading senior care referral service with Family ... for Seniors to Live. All 50 states and 302 cities in the U.S. were ... development. , According to the U.S. Census Bureau , almost 20 million ...
(Date:10/8/2019)... ... 2019 , ... What unique insights can three former Surgeons General of the ... the nation? That question will be answered at ICAA 2019: Shaping the Future of ... event will take place October 10-12, 2019, at the Gaylord Palms Resort and Convention ...
(Date:10/8/2019)... ... October 08, 2019 , ... Dr. Amir HagShenas of Silicon Valley Smile Solutions ... relief from this common and treatable condition. Dr. HagShenas’ goal is to treat ... with uncomfortable symptoms, including tender and bleeding gums, and to prevent gum disease from ...
Breaking Medicine News(10 mins):